The assay screens for small molecule inhibitors that block the interaction of thyroid receptor (TR) with steroid receptor coregulator 2 (SRC2) and lead to a decrease in fluorescence polarization. TR modulators are potential therapies for obesity and hyperlipidemia, but current thyroid analogs cause unwanted side effects such as cardiac stimulation. The assay aims to identify inhibitors with specific blocking abilities to prevent these unwanted side effects. Is the molecule effective to this assay?